These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35682669)

  • 1. Inhibition of Respiratory Syncytial Virus Infection by Small Non-Coding RNA Fragments.
    Pålsson SA; Sekar V; Kutter C; Friedländer MR; Spetz AL
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-Stranded Oligonucleotide-Mediated Inhibition of Respiratory Syncytial Virus Infection.
    Pålsson SA; Dondalska A; Bergenstråhle J; Rolfes C; Björk A; Sedano L; Power UF; Rameix-Welti MA; Lundeberg J; Wahren-Herlenius M; Mastrangelo P; Eleouet JF; Le Goffic R; Galloux M; Spetz AL
    Front Immunol; 2020; 11():580547. PubMed ID: 33363532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of two novel functional tRNA-derived fragments induced in response to respiratory syncytial virus infection.
    Zhou J; Liu S; Chen Y; Fu Y; Silver AJ; Hill MS; Lee I; Lee YS; Bao X
    J Gen Virol; 2017 Jul; 98(7):1600-1610. PubMed ID: 28708049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and functional characterization of tRNA-derived RNA fragments (tRFs) in respiratory syncytial virus infection.
    Wang Q; Lee I; Ren J; Ajay SS; Lee YS; Bao X
    Mol Ther; 2013 Feb; 21(2):368-79. PubMed ID: 23183536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long Noncoding RNA NRAV Promotes Respiratory Syncytial Virus Replication by Targeting the MicroRNA miR-509-3p/Rab5c Axis To Regulate Vesicle Transportation.
    Li J; Li M; Wang X; Sun M; Ma C; Liang W; Gao X; Wei L
    J Virol; 2020 May; 94(10):. PubMed ID: 32102886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and evaluation of a novel tribenzamide derivative as an inhibitor targeting the entry of the respiratory syncytial virus.
    Issmail L; Ramsbeck D; Jäger C; Henning T; Kleinschmidt M; Buchholz M; Grunwald T
    Antiviral Res; 2023 Mar; 211():105547. PubMed ID: 36682463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of Respiratory Syncytial Virus (RSV) Memphis Strain 37 (M37) Infection in the Respiratory Tract of Newborn Lambs as an RSV Infection Model for Human Infants.
    Larios Mora A; Detalle L; Van Geelen A; Davis MS; Stohr T; Gallup JM; Ackermann MR
    PLoS One; 2015; 10(12):e0143580. PubMed ID: 26641081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory syncytial virus fusion nanoparticle vaccine immune responses target multiple neutralizing epitopes that contribute to protection against wild-type and palivizumab-resistant mutant virus challenge.
    Gilbert BE; Patel N; Lu H; Liu Y; Guebre-Xabier M; Piedra PA; Glenn G; Ellingsworth L; Smith G
    Vaccine; 2018 Dec; 36(52):8069-8078. PubMed ID: 30389195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Cellular and Viral circRNAome Induced by Respiratory Syncytial Virus Infection.
    Yao W; Pan J; Liu Z; Dong Z; Liang M; Xia S; Xiao Y; Cai X; Peng T; Zhou X; Cai H
    mBio; 2021 Dec; 12(6):e0307521. PubMed ID: 34872355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge.
    Wang D; Phan S; DiStefano DJ; Citron MP; Callahan CL; Indrawati L; Dubey SA; Heidecker GJ; Govindarajan D; Liang X; He B; Espeseth AS
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28298602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imiquimod suppresses respiratory syncytial virus (RSV) replication via PKA pathway and reduces RSV induced-inflammation and viral load in mice lungs.
    Salinas FM; Nebreda AD; Vázquez L; Gentilini MV; Marini V; Benedetti M; Nabaes Jodar MS; Viegas M; Shayo C; Bueno CA
    Antiviral Res; 2020 Jul; 179():104817. PubMed ID: 32387475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parent tRNA Modification Status Determines the Induction of Functional tRNA-Derived RNA by Respiratory Syncytial Virus Infection.
    Choi EJ; Wu W; Zhang K; Yuan X; Deng J; Ismail D; Buck DL; Thomason KS; Garofalo RP; Zhang S; Bao X
    Viruses; 2022 Dec; 15(1):. PubMed ID: 36680097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The alpha-1 subunit of the Na+,K+-ATPase (ATP1A1) is required for macropinocytic entry of respiratory syncytial virus (RSV) in human respiratory epithelial cells.
    Lingemann M; McCarty T; Liu X; Buchholz UJ; Surman S; Martin SE; Collins PL; Munir S
    PLoS Pathog; 2019 Aug; 15(8):e1007963. PubMed ID: 31381610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Basis for the Selective Inhibition of Respiratory Syncytial Virus RNA Polymerase by 2'-Fluoro-4'-Chloromethyl-Cytidine Triphosphate.
    Deval J; Hong J; Wang G; Taylor J; Smith LK; Fung A; Stevens SK; Liu H; Jin Z; Dyatkina N; Prhavc M; Stoycheva AD; Serebryany V; Liu J; Smith DB; Tam Y; Zhang Q; Moore ML; Fearns R; Chanda SM; Blatt LM; Symons JA; Beigelman L
    PLoS Pathog; 2015 Jun; 11(6):e1004995. PubMed ID: 26098424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging small and large molecule therapeutics for respiratory syncytial virus.
    Bergeron HC; Tripp RA
    Expert Opin Investig Drugs; 2020 Mar; 29(3):285-294. PubMed ID: 32096420
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of bioluminescence imaging of respiratory syncytial virus (RSV) in virus-infected live mice and its use for evaluation of therapeutics and vaccines.
    Fuentes S; Arenas D; Moore MM; Golding H; Khurana S
    Vaccine; 2017 Jan; 35(4):694-702. PubMed ID: 27989627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory syncytial virus: prospects for new and emerging therapeutics.
    Jorquera PA; Tripp RA
    Expert Rev Respir Med; 2017 Aug; 11(8):609-615. PubMed ID: 28574729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Verdinexor (KPT-335), a Selective Inhibitor of Nuclear Export, Reduces Respiratory Syncytial Virus Replication
    Jorquera PA; Mathew C; Pickens J; Williams C; Luczo JM; Tamir S; Ghildyal R; Tripp RA
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30541831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Labyrinthopeptins as virolytic inhibitors of respiratory syncytial virus cell entry.
    Blockus S; Sake SM; Wetzke M; Grethe C; Graalmann T; Pils M; Le Goffic R; Galloux M; Prochnow H; Rox K; Hüttel S; Rupcic Z; Wiegmann B; Dijkman R; Rameix-Welti MA; Eléouët JF; Duprex WP; Thiel V; Hansen G; Brönstrup M; Haid S; Pietschmann T
    Antiviral Res; 2020 May; 177():104774. PubMed ID: 32197980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luteolin inhibits respiratory syncytial virus replication by regulating the MiR-155/SOCS1/STAT1 signaling pathway.
    Wang S; Ling Y; Yao Y; Zheng G; Chen W
    Virol J; 2020 Nov; 17(1):187. PubMed ID: 33239033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.